Rovin Capital Medtronic PLC Transaction History

Rovin Capital

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$78.71 - $87.02 $48,878 - $54,039	621 Added 7.55%	8,846 $696,000
Q1 2024 Apr 22, 2024	BUY	$82.84 - $88.09 $28,082 - $29,862	339 Added 4.3%	8,225 $717,000
Q4 2023 Mar 12, 2024	BUY	$69.43 - $83.43 $99,909 - $120,055	1,439 Added 22.32%	7,886 $650,000
Q3 2023 Oct 25, 2023	SELL	$78.22 - $90.4 $43,412 - $50,172	-555 Reduced 7.93%	6,447 $505,000
Q2 2023 Aug 08, 2023	BUY	$79.47 - $91.38 $33,297 - $38,288	419 Added 6.36%	7,002 $617,000
Q1 2023 Apr 05, 2023	BUY	$76.72 - $87.58 $613 - $700	8 Added 0.12%	6,583 $531,000
Q4 2022 Jan 23, 2023	BUY	$76.18 - $87.74 $6,094 - $7,019	80 Added 1.23%	6,575 $511,000
Q3 2022 Oct 25, 2022	SELL	$80.75 - $95.31 $4,441 - $5,242	-55 Reduced 0.84%	6,495 $524,000
Q2 2022 Jul 22, 2022	BUY	$87.4 - $113.09 $3,321 - $4,297	38 Added 0.58%	6,550 $588,000
Q1 2022 Jun 13, 2022	BUY	$100.58 - $112.38 $88,409 - $98,782	879 Added 15.6%	6,512 $723,000
Q4 2021 Feb 24, 2022	BUY	$99.53 - $127.75 $560,652 - $719,615	5,633 New	5,633 $583,000

2,286

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $115B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Rovin Capital , based on Form 13F filings with the SEC.

Stay updated on Rovin Capital with notifications on news.